4 June 2014
ASLAN presents at the Boston CEO conference
in the US
14 May 2014
BioWorld features licensing deal for ASLAN004
13 May 2014
ASLAN announces global license agreement
with CSL


Our Model
ASLAN inlicenses preclinical candidate drugs and takes them to proof-of-concept, leveraging high quality resources in Asia, then offers them back to the originator or other pharma companies for late phase global development.
Partnering
ASLAN is currently looking to inlicense preclinical and early development compounds into our pipeline across a variety of therapeutic areas



Home | Our Model Our Team Our Board | Pipeline | Asset Partners | Latest News | Careers
    Our Advisors Our Investors         Execution Partners   Archive   Location

Copyright ©2010 ASLAN Pharmaceuticals Pte Ltd